71 patents
Page 3 of 4
Utility
Use of cannabidiol in the treatment of epilepsy
16 Feb 21
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC).
Geoffrey Guy, Stephen Wright, Elizabeth Thiele
Filed: 13 Oct 15
Utility
Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders
26 Jan 21
The present invention relates to the use of cannabidiolic acid (CBDA) in the treatment of autism spectrum disorder (ASD) and ASD-associated disorders, such as Fragile X syndrome (FXS); Rett syndrome (RS); or Angelman syndrome (AS).
Geoffrey Guy, Stephen Wright, James Brodie, Marie Woolley-Roberts, Rafael Maldonado, Daniela Parolaro, Livio Luongo
Filed: 11 Apr 17
Utility
Cannabidiol Preparations and Its Uses
21 Jan 21
Cannabidiol (CBD) is a cannabinoid designated chemically as 2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol.
Geoffrey GUY, Volker Knappertz, Benjamin Whalley, Marie Woolley-Roberts, James Brodie, Katarzyna Lach-Falcone, Alan Sutton, Royston Gray, Rohini Rajyalaxmi Rana
Filed: 3 Sep 20
Utility
Use of cannabinoids in the treatment of epilepsy
30 Nov 20
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 20 Nov 18
Utility
Use of Cannabinoids In the Treatment of Epilepsy
25 Nov 20
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey GUY, Stephen WRIGHT, Orrin DEVINSKY
Filed: 9 Aug 20
Utility
Use of Cannabinoids In the Treatment of Epilepsy
11 Nov 20
The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with childhood-onset epilepsy who are concurrently taking one or more antiepileptic drugs that works via GABA receptor agonism.
Geoffrey GUY, Volker KNAPPERTZ, Benjamin WHALLEY
Filed: 21 Jan 19
Utility
Pharmaceutical formulation
19 Oct 20
The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray.
Brian Anthony Whittle
Filed: 2 Dec 19
Utility
Use of Cannabinoids In the Treatment of Epilepsy
14 Oct 20
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey GUY, Stephen WRIGHT, Orrin DEVINSKY
Filed: 24 Jun 20
Utility
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
12 Oct 20
This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy.
Ben Whalley, Claire Williams, Gary Stephens, Takashi Futamura
Filed: 13 Apr 15
Utility
Extraction of Pharmaceutically Active Components from Plant Materials
30 Sep 20
The invention relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance (BDS) for incorporation in to a medicament.
Brian Anthony Whittle, Colin A. Hill, Ian R. Flockhart, David Victor Downs, Peter Gibson, Gary William Wheatley
Filed: 29 Oct 19
Utility
Use of Cannabinoids In the Treatment of Epilepsy
23 Sep 20
The present invention relates to the use of cannabidiol (CBD) in the treatment of focal seizures.
Geoffrey GUY, Stephen Wright, Orrin Devinsky
Filed: 3 Jun 20
Utility
Use of cannabidiol in the treatment of epilepsy
7 Sep 20
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of seizures associated with Aicardi Syndrome.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 13 Oct 15
Utility
Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour
31 Aug 20
The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer.
Wai Liu, Katherine Scott, Angus Dalgleish, Marnie Duncan, Colin Stott
Filed: 1 May 18
Utility
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
3 Aug 20
This invention relates to a pharmaceutical composition comprising or consisting essentially of the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD).
Benjamin Whalley, Claire Williams, Gary Stephens, Thomas Hill
Filed: 13 Sep 12
Utility
Use of Cannabidiol In Combination with 5-HT2B Receptor Agonists or Amphetamins In the Treatment of Epilepsy
29 Jul 20
The present invention relates to the use of cannabidiol (CBD) in combination with an agonist of 5-HT2B receptors.
Benjamin WHALLEY, Geoffrey GUY, Volker KNAPPERTZ, Royston GRAY, Rohini RANA
Filed: 30 Sep 18
Utility
Use of cannabinoids in the treatment of epilepsy
13 Jul 20
The present invention relates to the use of cannabidiol (CBD) in the treatment of focal seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 15 Jun 16
Utility
Use of cannabinoids in the treatment of epilepsy
13 Jul 20
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy
Filed: 12 Sep 19
Utility
Use of cannabinoids in the treatment of epilepsy
13 Jul 20
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Orrin Devinsky
Filed: 7 Nov 19
Utility
Compositions Comprising Cannabinoids for Treatment of Nausea, Vomiting, Emesis, Motion Sickness or Like Conditions
1 Jul 20
Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness.
BRIAN ANTHONY WHITTLE, Farideh Afshin Javid
Filed: 5 Aug 19
Utility
7-OH-CANNABIDIOL (7-OH-CBD) And/or 7-OH-CANNABIDIVARIN (7-OH-CBDV) for Use In the Treatment of Epilepsy
1 Jul 20
The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy.
Colin Stott, Nick Jones, Benjamin Whalley, Gary Stephens, Claire Williams
Filed: 2 Oct 19